1-methyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole → 5-Methyl-2-(1-methyl-1H-pyrazol-5-yl)benzoic acid
Reaktionsgleichung
[CH3:1][C:2]1[CH:3]=[CH:4][C:5]([C:11]2[CH:12]=NN(C)C=2)=[C:6]([CH:10]=1)[C:7]([OH:9])=[O:8].[CH3:17][N:18]1C(B2OC(C)(C)C(C)(C)O2)=C[CH:20]=[N:19]1>>[CH3:1][C:2]1[CH:3]=[CH:4][C:5]([C:11]2[N:19]([CH3:20])[N:18]=[CH:17][CH:12]=2)=[C:6]([CH:10]=1)[C:7]([OH:9])=[O:8]Komponenten
3
Versuchsvorschrift
The title compound was synthesized following the same general protocol as described for 5-methyl-2-(1-methyl-1H-pyrazol-4-yl)benzoic acid in Example A1, using 1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole. ESI-MS (m/z): 217 [M+1]+.
Quellen und Nachweise
- ORD-Eintrag
- ord-abec4444dbb34b1f9665e18a6537c517
- Quelldatensatz
- uspto-grants-2016_09
- Patentnummer
- US09440982B2
Notizen zur Reaktion
Wird geladen…